Resuscitation of Traumatic Hemorrhagic Shock Patients With Hypertonic Saline—Without Dextran—Inhibits Neutrophil and Endothelial Cell Activation

ABSTRACT Posttraumatic inflammation and excessive neutrophil activation cause multiple organ dysfunction syndrome (MODS), a major cause of death among hemorrhagic shock patients. Traditional resuscitation strategies may exacerbate inflammation; thus, novel fluid treatments are needed to reduce such posttraumatic complications. Hypertonic resuscitation fluids inhibit inflammation and reduce MODS in animal models. Here we studied the anti-inflammatory efficacy of hypertonic fluids in a controlled clinical trial. Trauma patients in hypovolemic shock were resuscitated in a prehospital setting with 250 mL of either 7.5% hypertonic saline (HS; n = 9), 7.5% hypertonic saline + 6% dextran 70 (HSD; n = 8), or 0.9% normal saline (NS; n = 17). Blood samples were collected on hospital admission and 12 and 24 h after resuscitation. Multicolor flow cytometry was used to quantify neutrophil expression of cell-surface activation/adhesion (CD11b, CD62L, CD64) and degranulation (CD63, CD66b, CD35) markers as well as oxidative burst activity. Circulating concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVACM-1), P- and E-selectins, myeloperoxidase (MPO), and matrix metalloproteinase 9 (MMP-9) were assessed by immunoassay. Multiple organ dysfunction syndrome, leukocytosis, and mortality were lower in the HS and HSD groups than in the NS group. However, these differences were not statistically significant. Hypertonic saline prevented priming and activation and neutrophil oxidative burst and CD11b and CD66b expression. Hypertonic saline also reduced circulating markers of neutrophil degranulation (MPO and MMP-9) and endothelial cell activation (sICAM-1, sVCAM-1, soluble E-selectin, and soluble P-selectin). Hypertonic saline + 6% dextran 70 was less capable than HS of suppressing the upregulation of most of these activation markers. This study demonstrates that initial resuscitation with HS, but neither NS nor HSD, can attenuate posttraumatic neutrophil and endothelial cell activation in hemorrhagic shock patients. These data suggest that hypertonic resuscitation without dextran may inhibit posttraumatic inflammation. However, despite this effect, neither HS nor HSD reduced MODS in trauma patients with hemorrhagic shock.

[1]  E. Bulger,et al.  Increased Neutrophil Adenosine A3 Receptor Expression Is Associated With Hemorrhagic Shock and Injury Severity in Trauma Patients , 2011, Shock.

[2]  E. Bulger 7.5% saline and 7.5% saline/6% dextran for hypovolemic shock. , 2011, The Journal of trauma.

[3]  T. Koepsell,et al.  Long-term survival of adult trauma patients. , 2011, JAMA.

[4]  I. Stiell,et al.  Out-of-hospital Hypertonic Resuscitation After Traumatic Hypovolemic Shock: A Randomized, Placebo Controlled Trial , 2011, Annals of surgery.

[5]  W. Junger,et al.  Immune cell regulation by autocrine purinergic signalling , 2011, Nature Reviews Immunology.

[6]  J. Duchesne,et al.  Damage Control Resuscitation: From Emergency Department to the Operating Room , 2011, The American surgeon.

[7]  W. Junger,et al.  A3 Adenosine Receptor Inhibition Improves the Efficacy of Hypertonic Saline Resuscitation , 2011, Shock.

[8]  W. Junger,et al.  Hypertonic stress regulates T cell function via pannexin‐1 hemichannels and P2X receptors , 2010, Journal of leukocyte biology.

[9]  F. Granath,et al.  Early predictors of morbidity and mortality in trauma patients treated in the intensive care unit , 2010, Acta anaesthesiologica Scandinavica.

[10]  H. Pape,et al.  Current theories on the pathophysiology of multiple organ failure after trauma. , 2010, Injury.

[11]  W. Junger,et al.  Hypertonic saline up-regulates A3 adenosine receptor expression of activated neutrophils and increases acute lung injury after sepsis* , 2008, Critical care medicine.

[12]  I. Chaudry,et al.  Bench-to-bedside review: Latest results in hemorrhagic shock , 2008, Critical care.

[13]  S. Rizoli,et al.  Effects of hypertonic saline on the development of acute lung injury following traumatic shock , 2008 .

[14]  J. Jallo,et al.  Hypertonic saline: a clinical review , 2007, Neurosurgical Review.

[15]  E. Bulger,et al.  Hypertonic Resuscitation Modulates the Inflammatory Response in Patients With Traumatic Hemorrhagic Shock , 2007, Annals of surgery.

[16]  P. Insel,et al.  HYPERTONIC STRESS REGULATES T-CELL FUNCTION BY THE OPPOSING ACTIONS OF EXTRACELLULAR ADENOSINE TRIPHOSPHATE AND ADENOSINE , 2007, Shock.

[17]  C. Roussos,et al.  Neutrophil CD64 expression and serum IL-8: sensitive early markers of severity and outcome in sepsis. , 2006, Cytokine.

[18]  M. Dubick,et al.  HYPOTENSIVE RESUSCITATION OF SEVERE HEMORRHAGE (HEM) IN SWINE WITH 5% SALINE (HS) OR 7.5% SALINE/6% DEXTRAN (HSD) , 2006 .

[19]  D. Herndon,et al.  THE INHIBITION OF INDUCIBLE NITRIC OXIDE SYNTHASE IN OVINE SEPSIS MODEL , 2006, Shock.

[20]  W. Junger,et al.  Hypertonic saline enhances neutrophil elastase release through activation of P2 and A3 receptors. , 2006, American journal of physiology. Cell physiology.

[21]  K. Inaba,et al.  The Immunomodulatory Effects of Hypertonic Saline Resuscitation in Patients Sustaining Traumatic Hemorrhagic Shock: A Randomized, Controlled, Double-Blinded Trial , 2006, Annals of surgery.

[22]  C. Wade,et al.  Issues of concern regarding the use of hypertonic/hyperoncotic fluid resuscitation of hemorrhagic hypotension. , 2006, Shock.

[23]  Tso-Chou Lin,et al.  Neutrophil-Mediated Secretion and Activation of Matrix Metalloproteinase-9 During Cardiac Surgery with Cardiopulmonary Bypass , 2005, Anesthesia and analgesia.

[24]  G. Hempelmann,et al.  Circulating adhesion molecules in the critically ill: A comparison between trauma and sepsis patients , 1996, Intensive Care Medicine.

[25]  S. Fujishima,et al.  Neutrophil-mediated tissue injury and its modulation , 1995, Intensive Care Medicine.

[26]  P. Insel,et al.  A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors , 2004, Journal of leukocyte biology.

[27]  D. Hoyt,et al.  OSMOTIC REGULATION OF CELL FUNCTION AND POSSIBLE CLINICAL APPLICATIONS , 2004, Shock.

[28]  P. Rhee,et al.  cDNA profiling in leukocytes exposed to hypertonic resuscitation fluids. , 2003, Journal of the American College of Surgeons.

[29]  P. Insel,et al.  Hypertonic Stress Increases T Cell Interleukin-2 Expression through a Mechanism That Involves ATP Release, P2 Receptor, and p38 MAPK Activation* , 2003, The Journal of Biological Chemistry.

[30]  D. Hoyt,et al.  Hypertonic saline infusion: can it regulate human neutrophil function? , 2000, Shock.

[31]  O. Rotstein Novel strategies for immunomodulation after trauma: revisiting hypertonic saline as a resuscitation strategy for hemorrhagic shock. , 2000, The Journal of trauma.

[32]  D. Hoyt,et al.  Does the timing of hypertonic saline resuscitation affect its potential to prevent lung damage? , 2000, Shock.

[33]  D. Burris,et al.  Human neutrophil activation and increased adhesion by various resuscitation fluids , 2000, Critical care medicine.

[34]  J. Marshall,et al.  Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. , 1998, Journal of immunology.

[35]  H. Junger,et al.  Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38. , 1998, The Journal of clinical investigation.

[36]  D. Hoyt,et al.  Hypertonic saline resuscitation reduces neutrophil margination by suppressing neutrophil L selectin expression. , 1997, The Journal of trauma.

[37]  K. Ljungström,et al.  Safety of dextran in relation to other colloids--ten years experience with hapten inhibition. , 1993, Infusionstherapie und Transfusionsmedizin.

[38]  J. Falloon,et al.  Neutrophil granules in health and disease. , 1986, The Journal of allergy and clinical immunology.